Showing results (121-130 of 181) with videos related to
Sort By:
Pageof 19
Journal of Acquired Immune Deficiency Syndromes (1999)|July 28, 2011
Mitochondrial genomics and CD4 T-cell count recovery after antiretroviral therapy initiation in AIDS clinical trials group study 384Benjamin J Grady, David C Samuels, Gregory K Robbins, et al.Antimicrobial Agents and Chemotherapy|April 1, 2015
Novel dosing strategies increase exposures of the potent antituberculosis drug rifapentine but are poorly tolerated in healthy volunteersKelly E Dooley, Radojka M Savic, Jeong-Gun Park, et al.The Journal of Infectious Diseases|January 23, 2024
Prediction Models for Adverse Drug Reactions During Tuberculosis Treatment in BrazilFelipe Ridolfi, Gustavo Amorim, Lauren S Peetluk, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 6, 2018
Antiretroviral Concentrations in Hair Strongly Predict Virologic Response in a Large Human Immunodeficiency Virus Treatment-naive Clinical TrialMonica Gandhi, Peter Bacchetti, Igho Ofokotun, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 9, 2011
Translation of HLA-HIV associations to the cellular level: HIV adapts to inflate CD8 T cell responses against Nef and HLA-adapted variant epitopesCoral-Ann M Almeida, Corine Bronke, Steven G Roberts, et al.AIDS (London, England)|May 7, 2009
Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitor-sparing regimens for initial HIV treatmentRichard H Haubrich, Sharon A Riddler, A Gregory DiRienzo, et al.Antiviral Therapy|August 3, 2007
A randomized study of antiviral medication switch at lower- versus higher-switch thresholds: AIDS Clinical Trials Group Study A5115Sharon A Riddler, Hongyu Jiang, Allan Tenorio, et al.Medrxiv : the Preprint Server for Health Sciences|September 11, 2023
Pharmacogenetics of tuberculosis treatment toxicity and effectiveness in a large Brazilian cohortGustavo Amorim, James Jaworski, Marcelo Cordeiro-Santos, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 5, 2006
Pharmacogenetics of plasma efavirenz exposure after treatment discontinuation: an Adult AIDS Clinical Trials Group StudyHeather J Ribaudo, David W Haas, Camlin Tierney, et al.Pharmacogenetics and Genomics|May 31, 2018
Brain neurotransmitter transporter/receptor genomics and efavirenz central nervous system adverse eventsDavid W Haas, Yuki Bradford, Anurag Verma, et al.Pageof 19